[COVID-19感染和血液恶性病之间的相互作用--评论]
Zi-Heng Wang1, Jia-Yi Zhao1, Xiao-Feng Shi1
1Nanjing Medical University, Nanjing 211166, Jiangsu Province, China.
Zhongguo shi yan xue ye xue za zhi
|July 4, 2025
概括
血液性恶性瘤患者面临更高的COVID-19风险. 接种疫苗有好处,像单克隆抗体这样的治疗有助于恢复,但COVID-19可以延迟这些脆弱个体的治疗.
科学领域:
- 血液学 血液学 血液学
- 传染性疾病 传染性疾病
- 在瘤学瘤学.
背景情况:
- 患有血液性恶性瘤 (HM) 的患者面临2019年冠状病毒严重疾病 (COVID-19) 和较高死亡率的风险增加.
- COVID-19 感染可以通过延迟造血复苏和损害免疫力,对 HM 患者产生负面影响.
研究的目的:
- 审查COVID-19感染和血液恶性瘤之间的复杂相互作用.
- 讨论对患者脆弱性,治疗策略和疾病管理的影响.
主要方法:
- 对在HM患者中检查COVID-19的研究的文献综述.
- 对疫苗疗效,治疗结果和对癌症治疗的影响进行分析.
主要成果:
- 虽然HM患者的疫苗反应减少,但仍能获得预防感染和严重疾病的保护.
- 单克隆抗体和抗病毒药物对HM患者的COVID-19治疗有益.
- COVID-19可能需要对HM患者的放射治疗和化疗强度和持续时间进行调整.
结论:
- 尽管面临挑战,但COVID-19疫苗接种对HM患者提供了好处.
- 综合管理策略对于应对HM患者的COVID-19至关重要.
- 需要进一步的研究,以优化对这一脆弱群体的护理.
相关概念视频
Regulation of Hematopoietic Stem Cells
3.3K
All blood and immune cells are produced from the multipotent hematopoietic stem cells (HSCs) by the process of hematopoiesis. However, they all have a limited life span. In addition, many are depleted in immune surveillance or combatting an injury or infection. This makes blood one of the most regenerative tissues. Hematopoiesis helps replenish these blood and immune cells, restoring the body's normal functioning. However, overproduction of blood and immune cells can make them cancerous or...
3.3K
Bone Marrow Sampling and Transplants
504
Bone marrow transplant is a potential cure for several diseases, including cancer and specific genetic disorders. Notably, this procedure is applicable for patients suffering from aplastic anemia, certain types of leukemia, severe combined immunodeficiency disease (SCID), Hodgkin's disease, non-Hodgkin's lymphoma, multiple myeloma, thalassemia, sickle-cell disease, and certain cancers.
The transplant begins with high doses of chemotherapy and radiation treatment, which aim to destroy...
The transplant begins with high doses of chemotherapy and radiation treatment, which aim to destroy...
504
Disorders of Leukocytes
1.2K
Leukocyte disorders can lead to either leukopenia, characterized by an abnormally low leukocyte count, or leukocytosis, marked by a very high leukocyte number.
Leukopenia may result from bone marrow disorders, autoimmune diseases, and infectious diseases. For example, conditions such as multiple myeloma and aplastic anemia can impair the bone marrow's ability to produce adequate leukocytes. Similarly, autoimmune diseases like lupus and viral infections such as HIV can prompt the immune...
Leukopenia may result from bone marrow disorders, autoimmune diseases, and infectious diseases. For example, conditions such as multiple myeloma and aplastic anemia can impair the bone marrow's ability to produce adequate leukocytes. Similarly, autoimmune diseases like lupus and viral infections such as HIV can prompt the immune...
1.2K
Role of Hematopoietic Growth Factors
1.7K
Hematopoietic growth factors are molecules that regulate the differentiation rate of hematopoietic stem cells (HSCs). Erythropoietin (EPO), primarily produced by the kidneys, plays a crucial role in erythrocyte production. When oxygen levels in the blood are low, EPO is released into the bloodstream, reaching the bone marrow, where it stimulates HSCs to differentiate and mature into erythrocytes, which are vital for oxygen transport.
Thrombopoietin (TPO), mainly released by the liver,...
Thrombopoietin (TPO), mainly released by the liver,...
1.7K
Immunodeficiency Diseases
1.2K
Immunodeficiency disorders are conditions in which the immune system's ability to fight infectious disease and cancer is compromised or entirely absent. The immune system comprises a complex network of cells, tissues, and organs that work together to protect the body from potentially harmful invaders. When this system is deficient or not functioning properly, it leaves the body susceptible to infections, diseases, or other complications.
There are three main causes of immunodeficiency...
There are three main causes of immunodeficiency...
1.2K
Hematopoiesis
5.7K
The process of blood cell formation is called hematopoiesis. Hematopoiesis starts early during development, on the seventh day of embryogenesis. This phase of hematopoiesis is called the primitive wave, wherein the extraembryonic yolk sac allows the production of erythroid cells and endothelial cells from a common precursor called hemangioblast. The erythroid cells provide oxygen to support the growth of the rapidly dividing embryo. Hemangioblasts later develop into hematopoietic stem cells or...
5.7K


